209 related articles for article (PubMed ID: 33019444)
1. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.
Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S
Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444
[TBL] [Abstract][Full Text] [Related]
2. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA
Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257
[TBL] [Abstract][Full Text] [Related]
3. A short report of novel
Song Y; Hou J; Wan L; Liu K; Zhou C; Wei S; Zhang G; Lin D; Li Y; Fang Q; Liu Y; Gong B; Gong X; Wang Y; Wei H; Wang J; Mi Y
Hematology; 2022 Dec; 27(1):518-522. PubMed ID: 35544458
[TBL] [Abstract][Full Text] [Related]
4. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W
Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344
[TBL] [Abstract][Full Text] [Related]
5. Acute Myeloid Leukemia with
Tao S; Song L; Deng Y; Chen Y; Shi Y; Gan Y; Deng Z; Ding B; He Z; Wang C; Yu L
Onco Targets Ther; 2020; 13():10559-10566. PubMed ID: 33116634
[TBL] [Abstract][Full Text] [Related]
6. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.
Cheng CK; Chan HY; Yung YL; Wan TSK; Leung AWK; Li CK; Tian K; Chan NPH; Cheung JS; Ng MHL
Blood Adv; 2022 Jan; 6(2):410-415. PubMed ID: 34673934
[TBL] [Abstract][Full Text] [Related]
7. A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia.
Zhang J; Shen H; Song H; Shen D; Liao C; Fang M; Wang Y; Tang Y; Zhu H
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e665-e671. PubMed ID: 35319505
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation.
Wu D; Gao R
Hematology; 2023 Dec; 28(1):2227495. PubMed ID: 37387408
[TBL] [Abstract][Full Text] [Related]
9. A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia.
Luo H; Zhang S; Li K; Chen XH; Li YC; Sun Y; Liu LF; Yu HY; Zhu HH
Leuk Res; 2019 Feb; 77():14-16. PubMed ID: 30612054
[No Abstract] [Full Text] [Related]
10. Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature.
Sun Y; Wang C; Sun Y; Wang J; Rong C; Wu A; Ouyang G; Sheng L
Medicine (Baltimore); 2021 Feb; 100(5):e24385. PubMed ID: 33592885
[TBL] [Abstract][Full Text] [Related]
11. Case report: A rare case of acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia.
Zhao J; Wang W; Yan L; Chen X; Li W; Li W; Chen T; Chen L
Front Oncol; 2022; 12():1011023. PubMed ID: 36185228
[No Abstract] [Full Text] [Related]
12. A global study for acute myeloid leukemia with RARG rearrangement.
Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
Han X; Jin C; Zheng G; Li Y; Wang Y; Zhang E; Zhu H; Cai Z
Ther Adv Hematol; 2021; 12():2040620720976984. PubMed ID: 33473264
[TBL] [Abstract][Full Text] [Related]
15. Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia.
Wu H; Li H; Zhou X; Zhao Z; Cao P; Li L; Ma X; Yuan L; Wang F; Zhang Y; Chen J; Fang J; Liu M; Liu M; Chen X; Liu H
Hematol Oncol; 2023 Oct; 41(4):784-788. PubMed ID: 37132198
[TBL] [Abstract][Full Text] [Related]
16. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
17. [Detection of PML/RARalpha gene rearrangement in suspected acute promyelocytic leukemia patients using dual-color fluorescence in situ hybridization on bone marrow smears].
Zhu YL; Wu YF; Pan JL; Xue YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):757-60. PubMed ID: 15631655
[TBL] [Abstract][Full Text] [Related]
18. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
19. In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
Such E; Cordón L; Sempere A; Villamón E; Ibañez M; Luna I; Gómez-Seguí I; López-Pavía M; Alonso C; Lo-Coco F; Cervera J; Sanz MA
Ann Hematol; 2014 Nov; 93(11):1931-3. PubMed ID: 24728721
[No Abstract] [Full Text] [Related]
20. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
